Brand-new Clinical Trial Centre Opens, Revolutionising the Field of Clinical Research in Australia
Terre Property Partners (Terre) has officially welcomed Veritus Research (Veritus) as it opens its purpose built First in Human Clinical Trials facility within Mountain Highway Business Park, in Melbourne’s east.
Having undertaken an extensive multi-million-dollar refurbishment of a 3,238 square metre building, Terre has created a life sciences hub within Mountain Highway Business Park, attracting like-minded groups to capitalise on the continued growth of the sector in Melbourne’s eastern corridor.
Veritus has launched a state-of-the-art clinical trials facility that specialises in conducting Early Phase First in Human (FIH) studies, providing a clinically safe environment for participants. Ultimately, this new clinical trial centre will allow Australia to contribute to the development of new treatments to fight diseases on a global scale.
The new clinical trial centre joins existing bio-technology groups Crux Biolabs, Vivo Pharm and Merck Life Sciences at Mountain Highway Business Park, which also boasts Siemens’ Australian headquarters as well as energy storage technology company Evo Power’s manufacturing and distribution centre. Other notable tenants include Motor One, who operate manufacturing and logistics operations within the business park; the logistics operations of assisted employment group Knoxbrooke Incorporated and Fire Equipment Services, the commercial arm of the State Government’s Fire Rescue Victoria department.
Veritus Research provides a 42-bed residential clinical facility, together with an 8-bed outpatient clinic, a, in a safe and controlled environment. As well as patients, Veritus will bring together, Doctors, Nurses, Pharmacists, Scientists, and support staff in one place, dedicated to providing best in class Clinical Trial services.
The 10-hectare Mountain Highway Business Park is located 28 radial kilometres from Melbourne’s CBD in the established Bayswater precinct of Melbourne’s outer east. The site offers close proximity to major road, public transport and critical healthcare infrastructure.
In keeping with their sustainable vision for all their projects, Terre purchased the property in 2018 and has undertaken significant redevelopment of existing buildings and construction of new purpose-built facilities featuring green design initiatives including solar PV, intelligent lighting control, rainwater harvesting, EV charging stations and energy monitoring systems.
Terre Property Partners CEO, Mark Brammy, is delighted to be the development and ongoing partner for this innovative and modern clinical trials facility.
“Our vision for Bayswater was always to evolve and become a leader in providing innovative development solutions to our customers by creating an epicentre for biotechnology and high-tech manufacturing, capitalising on substantial growth in these sectors.
“We purchased this site in 2018 with a vision of creating a Business Park with a mix of businesses with heightened technology, which has now evolved to medical technology, research, and testing.
“The COVID-19 pandemic has been a wake-up call for Australia in regard to the importance of sovereign capability, and we want to capitalise and spearhead the resurgence of medical research to Australian shores,” Mark concluded.
Veritus CEO Cheryl-Ann Hawkins added how the company is excited to launch its new clinical trial facility noting, “With the growth of vaccines and therapeutic products, Veritus Research is providing Australia with a state-of-the-art Clinical Trial facility that will attract clinical trials from all over the world and demonstrate Australia’s ability to conduct world class clinical trials.
“This new clinical trial facility will contribute to the development of essential medicines for the Australian population, which is paramount. Medicine’s growth of the past 50 years has been built on scientific understanding translating into development of new drugs and these drugs need to be tested to ensure their effectiveness and safety.
“We have been fundamental to this process in the fields of arthritis, weight management, cardiac disease, nerve damage, infection prevention and many other disease states.
“This gives people earlier access to important treatments and allows the introduction of new, valuable treatments for the entire population.
“Our new space also seamlessly integrates luxury with scientific innovation, with the inclusion of a garden, access to walking trails, chef prepared meals, and office spaces offering participants a unique experience and ensuring that their comfort and safety is our primary priority,” Cheryl-Ann concluded.